Anti-PI 3 Kinase p85 alpha antibody [M253]
- BOND RX™ Validated
- What is this?
5
(10 Reviews)
|
(219 Publications)
Mouse Monoclonal PI 3 Kinase p85 alpha antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 219 publications. Immunogen corresponding to Recombinant Fragment Protein within Human PIK3R1.
View Alternative Names
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [M253] (AB86714)
Immunocytochemical labeling of PI 3 Kinase p85 in aldehyde-fixed and NP-40-permeabilized A431 cells. The cells were labeled with ab86714, then the antibody was detected using appropriate secondary antibody conjugated to DyLight® 594.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [M253] (AB86714)
ICC/IF image of ab86714 stained SKNSH cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum (ab7481) / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab86714, 5μg/ml) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) (ab96871) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI 3 Kinase p85 alpha antibody [M253] (AB86714)
IHC image of PI 3 Kinase p85 staining in Human skeletal muscle formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (ab64236) (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab86714, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
Unknown
Western blot - Anti-PI 3 Kinase p85 alpha antibody [M253] (AB86714)
Lane 1:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [M253] (ab86714) at 1/1000 dilution
Lane 2:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [M253] (ab86714) at 1/2000 dilution
Lane 3:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [M253] (ab86714) at 1/4000 dilution
All lanes:
A431 cell lysate
Predicted band size: 83 kDa
Observed band size: 85 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P85 alpha modulates intracellular signaling by interacting with other proteins in a complex formation with catalytic subunit p110. This interaction enables the initiation of downstream signaling cascades controlling cell growth proliferation and survival. PI 3 kinase activity mediated by p85 alpha is integral to cellular homeostasis and metabolism helping to execute cellular responses to a variety of growth factors and hormones.
Pathways
PI 3 Kinase p85 alpha integrates into two principal signaling networks: the PI3K-Akt and mTOR pathways. These pathways are instrumental for regulating anabolic processes and cell survival. The p85 form of PI3K interacts with additional proteins such as Akt and mTOR coordinating cellular energy balance promoting protein synthesis and inhibiting apoptosis. Through these interactions the protein ensures that cells respond accurately to nutritional and stress signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (219)
Recent publications for all applications. Explore the full list and refine your search
Journal of clinical immunology 45:139 PubMed41026257
2025
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 14: PubMed40867839
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:439 PubMed40514650
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 25:66 PubMed39984956
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of international medical research 53:3000605231220807 PubMed39921429
2025
Applications
Unspecified application
Species
Unspecified reactive species
Asian Pacific journal of cancer prevention : APJCP 25:3807-3815 PubMed39611903
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pulmonary circulation 14:e12439 PubMed39411231
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of general medicine 17:3293-3318 PubMed39081673
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:16878 PubMed39043740
2024
Applications
Unspecified application
Species
Unspecified reactive species
Iranian journal of basic medical sciences 27:439-446 PubMed38419890
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com